EVOLUS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EVOLUS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $4.17M, a 3724.77% increase year-over-year.
- EVOLUS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $46.79M, a 179876.92% increase year-over-year.
- EVOLUS, INC. stock issued during period, value, new issues for the quarter ending 2023-12-31 was $29.00K.
- EVOLUS, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $60.00K, a 83.10% decline year-over-year.
- EVOLUS, INC. stock issued during period, value, new issues for fiscal 2024 was $50.96M, a 22651.34% increase from fiscal 2023.
- EVOLUS, INC. stock issued during period, value, new issues for fiscal 2023 was $224.00K, a 58.44% decline from fiscal 2022.
- EVOLUS, INC. stock issued during period, value, new issues for fiscal 2022 was $539.00K, a 17.71% decline from fiscal 2021.
- EVOLUS, INC. stock issued during period, value, new issues for fiscal 2021 was $655.00K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-12-31 | $50.96M 10-K · filed 2026-03-03 | |
| 2024-06-30 | $4.17M 10-Q · filed 2025-11-05 | $51.05M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-03-31 | $46.79M 10-Q · filed 2025-11-05 | $46.99M derived: sum of 4 quarters · filed 2025-11-05 |
| 2023-12-31 | $29.00K derived: 10-K 12 month − 3 quarters · filed 2024-03-07 | $224.00K 10-K · filed 2024-03-07 |
| 2023-09-30 | $60.00K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $109.00K 10-Q · filed 2023-11-07 | |
| 2023-03-31 | $26.00K 10-Q · filed 2023-11-07 | |
| 2022-12-31 | $539.00K 10-K · filed 2024-03-07 | |
| 2022-09-30 | $355.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $167.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $17.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $655.00K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $644.00K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $11.00K 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-03 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $2.46M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $314.00K 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $853.00K 10-Q · filed 2020-10-29 | |
| 2019-03-31 | -$58.00K 10-Q · filed 2020-10-29 | |
| 2018-09-30 | $67.38M 10-Q · filed 2019-11-04 | |
| 2018-03-31 | $53.45M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |